Foster Dykema Cabot & CO Inc Eli Lilly & CO Transaction History

Foster Dykema Cabot & CO Inc

$827 Million
Q3 2023

A detailed history of Foster Dykema Cabot & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 53,922 shares of LLY stock, worth $40.2 Million. This represents 3.5% of its overall portfolio holdings.

Number of Shares

53,922

Previous 54,037 0.21%

Holding current value

$40.2 Million

Previous $25.3 Million 14.29%

% of portfolio

3.5%

Previous 2.98%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $49,990 - $68,919	-115 Reduced 0.21%	53,922 $29 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $38,932 - $52,056	-111 Reduced 0.2%	54,037 $25.3 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $384,559 - $451,647	1,238 Added 2.34%	54,148 $18.6 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $3.08 Million - $3.59 Million	9,579 Added 22.11%	52,910 $19.4 Million
Q3 2022 Feb 03, 2023	SELL	$296.48 - $337.87 $2.84 Million - $3.24 Million	-9,579 Reduced 18.1%	43,331 $14 Million
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $11.9 Million - $13.6 Million	40,278 Added 1319.29%	43,331 $14 Million
Q3 2021 Oct 25, 2021	BUY	$221.6 - $272.71 $281,210 - $346,068	1,269 Added 71.13%	3,053 $705,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $9,859 - $12,763	-60 Reduced 3.25%	1,784 $333,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $14,872 - $19,679	114 Added 6.59%	1,844 $311,000
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $3,070 - $3,551	-21 Reduced 1.2%	1,730 $256,000
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $2,864 - $3,447	21 Added 1.21%	1,751 $287,000
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $184,971 - $229,103	1,730 New	1,730 $227,000
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $443,178 - $482,064	-4,150 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $177,042 - $206,653	-1,598 Reduced 27.8%	4,150 $460,000
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $185,325 - $207,620	-1,750 Reduced 23.34%	5,748 $665,000
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $150,255 - $187,792	-1,750 Reduced 18.92%	7,498 $805,000
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $782,363 - $839,173	-9,548 Reduced 50.8%	9,248 $781,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.45 Million - $1.61 Million	18,796	18,796 $1.61 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & CO Inc with notifications on news.

Account

Foster Dykema Cabot & CO Inc Eli Lilly & CO Transaction History